EIF2AK4 and systemic lupus erythematosus: Consistently, myeloid deletion of GCN2 in lupus-prone mice results in increased immune cell activation, humoral autoimmunity, renal pathology, and mortality, while activation of GCN2 was found to significantly reduce these symptoms of systemic autoimmune disease [131].